≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

DOID EFO Endpoint Browser

CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS

lymphoma: A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C96
  • Hospital discharge: ICD-9 — 202
  • Hospital discharge: ICD-8 — 202
  • Cause of death: ICD-10 — C96
  • Cause of death: ICD-9 — 202
  • Cause of death: ICD-8 — 202

2 out of 7 registries used, show all original rules.

329

4. Check minimum number of events

None

329

5. Include endpoints

None

329

6. Filter based on genotype QC (FinnGen only)

320

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C81-C96
Name in latin
Neoplasmata maligna alia et non specificata textus lymphatici, haematopoetici et cognati

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 320 145 175
Unadjusted period prevalence (%) 0.07 0.05 0.08
Median age at first event (years) 58.07 54.03 61.42

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
329
Matched controls
3290
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
42.6
255.8
183
94
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
186.8
161
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
33.1
80.0
53
19
XW000
NOMESCO Finland
Bone marrow biopsy
13.3
79.3
85
84
L03AA02
ATC
filgrastim; parenteral
17.4
72.7
64
45
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
28.9
62.4
43
17
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.8
53.2
69
87
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
+∞
45.9
43
*
A04AA01
ATC
ondansetron; systemic, rectal
6.0
36.0
74
152
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
7.0
35.2
60
102
JN4BD
NOMESCO Finland
Extensive body CT
5.1
35.2
93
238
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
34.4
136
474
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
10.0
34.1
41
46
M04AA01
ATC
allopurinol; systemic
4.4
30.2
98
292
WW500
NOMESCO Finland
Blood transfusion
6.8
29.0
49
82
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
9.3
28.4
36
43
C96.2
ICD-10 Finland
Malignant mast cell tumour
+∞
26.4
25
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
25.3
24
*
JN4AD
NOMESCO Finland
Body CT examination
4.3
23.6
71
197
H02AB02
ATC
dexamethasone; systemic
4.0
23.2
78
235
C96.7
ICD-10 Finland
Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
+∞
22.1
21
*
R50.9
ICD-10 Finland
Fever, unspecified
3.6
21.3
89
310
Q82.2
ICD-10 Finland
Mastocytosis
+∞
21.1
20
*
ZX120
NOMESCO Finland
Intravenous
4.0
20.5
67
197
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
111.8
19.8
21
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.9
19.5
37
69
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
20.9
18.5
27
14
H02AB06
ATC
prednisolone; systemic
2.8
18.3
201
1180
WF049
NOMESCO Finland
Radiotherapy of metastasis
6.3
18.3
32
55
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
44.7
17.5
21
5
1XC02, ,
NOMESCO Finland
44.7
17.5
21
5
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.3
17.3
29
22
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
18.7
17.2
26
15
PJA10
NOMESCO Finland
Exploration of lymph nodes
18.7
17.2
26
15
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
167.6
15.6
16
*
N02AA05
ATC
oxycodone; systemic
2.9
15.6
98
426
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
15.4
69
247
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
14.9
15.3
25
18
A02BC02
ATC
pantoprazole; systemic
2.9
14.7
257
1817
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
156.7
14.6
15
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.5
14.0
142
775
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.1
13.8
68
257
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
13.6
13
*
20293
ICD-8 Finland
Other neoplasms of lymphoid tissue, Neoplasma benignum sive NUD medullae osseae
+∞
13.6
13
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
15.9
13.3
21
14
C82.1
ICD-10 Finland
Follicular lymphoma grade II
29.7
13.1
17
6
L03AA13
ATC
pegfilgrastim; parenteral
4.4
12.9
34
84
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
18.2
12.7
19
11
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.0
12.5
38
105
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
11.1
80
367
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
44.9
11.0
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
10.9
185
1217
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
29.1
10.8
14
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.7
10.8
36
106
C91.4
ICD-10 Finland
Hairy-cell leukaemia
62.1
10.7
12
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
62.1
10.7
12
*
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
62.1
10.7
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
9.7
10.7
21
23
2024A
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Leukaemic reticuloendotheliosis
+∞
10.5
10
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
10.5
10
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
16.7
10.5
16
10
JN6AD
NOMESCO Finland
CT of torso and neck
9.3
10.4
21
24
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
33.7
10.4
13
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
31.0
9.5
12
*
20228
ICD-8 Finland
Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue
+∞
9.4
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
9.3
93
490
ZXE00
NOMESCO Finland
One hour or less
2.1
9.1
142
887
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
4.6
9.0
22
51
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
24.8
9.0
12
5
R06AE07
ATC
cetirizine; oral
2.0
9.0
144
908
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
13.0
9.0
15
12
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
16.8
8.6
13
8
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
92.3
8.5
9
*
C90.0
ICD-10 Finland
Multiple myeloma
9.8
8.4
16
17
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
+∞
8.4
8
*
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
8.4
8
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
8.3
20
46
B01AB10
ATC
tinzaparin; parenteral
2.7
8.1
47
192
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
8.0
53
231
Z2221
NOMESCO Finland
Medical doctor
2.1
8.0
102
587
R4110
NOMESCO Finland
Physiotherapy
2.1
8.0
105
611
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
7.9
45
182
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
25.7
7.6
10
*
Z51.5
ICD-10 Finland
Palliative care
2.7
7.5
42
168
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
81.9
7.4
8
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
81.9
7.4
8
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
13.8
7.4
12
9
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
11.2
7.4
13
12
9741/3-C42.1
ICD-O-3
Malignant mastocytosis of bone marrow
+∞
7.3
7
*
9590/3-C80.9
ICD-O-3
Malignant lymphoma, NOS, of unknown primary site
+∞
7.3
7
*
2029X
ICD-9 Finland
Other malignant neoplasm of lymphoid and histiocytic tissue, Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
+∞
7.3
7
*
H02AB07
ATC
prednisone; oral
2.4
7.3
57
268
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.9
7.2
21
56
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
20.6
7.2
10
5
WX892
NOMESCO Finland
Monitored bed care
2.8
7.2
36
136
D70.82
ICD-10 Finland
Drug-induced neutropenia
6.6
7.0
17
27
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
7.0
41
168
JAH01
NOMESCO Finland
Laparoscopy
3.8
6.9
21
58
GD1AD
NOMESCO Finland
Thorax CT examination
3.2
6.8
28
94
B01AB05
ATC
enoxaparin; parenteral
1.9
6.8
121
774
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
12.6
6.6
11
9
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
71.2
6.4
7
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
71.2
6.4
7
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
6.3
67
356
WW300
NOMESCO Finland
Transfer of autologic stem cells
18.4
6.3
9
5
R4190
NOMESCO Finland
Nutritional therapy
3.8
6.3
19
52
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
6.3
6
*
C96.1
ICD-10 Finland
Malignant histiocytosis
+∞
6.3
6
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
6.3
6
*
I88.8
ICD-10 Finland
Other nonspecific lymphadenitis
+∞
6.3
6
*
C96.0
ICD-10 Finland
Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis [Letterer-Siwe disease]
+∞
6.3
6
*
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
6.3
6
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.9
6.2
18
48
ZX112
NOMESCO Finland
Subcutaneous
4.3
6.2
16
39
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
6.1
77
436
ZX108
NOMESCO Finland
Inhalation
12.8
6.1
10
8

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
60
24
30.35
87.53
1.4
1.2
—
—
—
0
0
66
38
21.48
83.09
1.5
1.2
—
—
—
0
0
112
169
9.53
76.27
1.3
1.4
—
—
—
0
0
133
265
7.75
70.16
1.4
1.5
—
—
—
0
0
130
309
6.30
55.97
1.5
1.5
—
—
—
0
0
61
61
12.05
55.71
1.5
1.8
—
—
—
0
0
138
373
5.65
50.91
1.6
1.8
—
—
—
0
0
105
247
5.77
44.71
1.8
1.4
—
—
—
0
0
255
1244
5.67
43.07
12.5
6.4
—
—
—
0
0
248
1251
4.99
38.23
11.1
5.9
2.78
2.75
%
0.07
241
1171
243
1211
4.85
37.98
11.0
5.9
0.66
0.64
%
0.21
236
1128
248
1258
4.95
37.76
11.5
6.2
9.60
8.77
%
2.22
241
1180
249
1287
4.84
36.43
11.2
6.0
27.34
27.00
%
0.14
242
1206
57
89
7.54
36.25
4.6
4.0
46.75
29.70
mg/l
1.02
48
70
253
1337
4.86
35.55
10.2
5.6
0.63
0.60
e9/l
1.15
226
1147
86
206
5.30
35.22
4.4
2.6
10.79
10.29
g/l
0.18
80
191
253
1343
4.83
35.17
10.2
5.6
0.04
0.04
e9/l
0.19
226
1154
56
89
7.38
35.00
4.6
4.0
55.88
131.11
mg/l
0.51
47
70
257
1383
4.92
35.00
10.9
5.9
0.17
0.19
e9/l
0.83
236
1215
245
1274
4.62
34.95
10.5
5.7
55.51
57.82
%
1.74
237
1195
175
721
4.05
34.94
5.6
2.8
338.79
6545.98
umol/l
2.87
169
617
254
1373
4.73
33.90
10.3
5.7
1.98
1.91
e9/l
0.12
237
1220
40
46
9.76
32.59
1.5
1.3
—
—
—
0
0
111
350
4.28
31.91
3.5
2.8
1.65
1.83
%
1.21
104
312
80
198
5.02
31.28
3.3
2.4
—
—
—
0
0
231
1211
4.05
31.10
9.0
4.8
33.41
35.13
g/l
4.23
225
1126
268
1558
4.88
31.09
21.7
9.5
4.08
4.17
e9/l
0.10
251
1370
253
1460
4.17
28.43
12.6
6.5
10.50
12.03
umol/l
1.57
248
1383
137
541
3.63
27.87
6.3
3.1
2.50
2.45
mmol/l
3.52
130
478
120
435
3.77
27.80
5.7
3.3
0.81
0.82
mmol/l
0.36
114
408
86
253
4.25
26.71
4.2
2.9
67.00
70.13
e9/l
0.28
64
195
41
65
7.06
25.45
1.5
1.2
—
—
—
0
0
173
841
3.23
24.34
8.1
3.8
7.40
7.40
ph
0.05
37
155
31
38
8.90
23.90
1.5
1.2
237.05
333.37
u/ml
0.48
20
19
65
168
4.58
23.73
3.2
1.7
1.60
1.52
g/l
0.06
60
151
39
64
6.78
23.40
5.2
4.7
—
—
—
0
0
232
1381
3.31
22.26
11.5
7.2
1.22
1.21
mmol/l
0.54
199
1177
146
671
3.11
22.17
17.9
6.6
—
—
—
0
0
219
1269
3.17
21.86
10.6
6.3
1.21
1.21
mmol/l
0.06
214
1142
178
936
2.96
20.88
7.6
3.4
2.35
2.35
mmol/l
0.11
164
813
103
401
3.28
20.54
2.4
2.3
21.18
22.42
%
0.37
93
353
161
812
2.92
20.25
7.8
4.7
—
—
—
0
0
106
425
3.20
20.07
2.3
2.3
2.16
2.30
g/l
1.72
100
393
72
236
3.63
18.70
7.8
4.6
1.27
0.98
%
0.35
53
99
29
19
16.61
18.34
2.1
1.9
28.60
33.28
%
0.57
29
19
109
466
3.00
18.23
2.4
2.3
11.73
12.84
umol/l
0.81
104
434
199
1166
2.79
18.16
17.5
10.2
0.02
0.00
e9/l
0.61
173
939
49
129
4.29
17.26
2.1
2.2
1.42
1.52
g/l
0.21
40
111
65
210
3.61
17.17
8.1
4.7
0.82
0.49
%
0.78
45
78
34
66
5.63
17.14
2.0
1.9
—
—
—
0
0
66
218
3.54
16.84
8.2
4.8
0.30
0.14
%
0.63
47
80
23
35
6.99
14.67
1.3
1.1
—
—
—
0
0
59
204
3.31
13.88
7.6
4.9
0.08
0.16
%
0.29
39
67
180
1098
2.41
13.73
3.9
2.6
370.51
146.10
ug/l
2.80
172
996
137
744
2.44
13.53
3.7
3.2
—
—
—
0
0
141
780
2.41
13.32
3.9
3.2
0.38
0.51
e6/l
0.37
115
591
78
325
2.84
13.23
4.6
2.9
8.27
9.06
umol/l
0.15
72
286
20
12
17.64
13.15
3.1
1.4
3304.20
903.08
u/ml
1.25
20
12
149
854
2.36
12.88
3.9
3.3
44.18
144.45
e6/l
0.69
123
664
62
232
3.06
12.73
7.5
7.1
11.99
9.99
mmol/l
0.88
57
219
275
2080
2.96
12.63
18.3
7.8
90.83
79.63
u/l
2.56
269
1938
132
723
2.38
12.60
2.2
2.0
3.06
3.10
mg/l
0.06
114
617
264
1958
2.76
12.56
6.7
4.1
18.27
12.77
mm/h
4.30
254
1781
35
91
4.18
12.44
2.8
2.3
21.91
22.00
s
0.03
35
83
22
38
6.13
12.43
2.4
2.4
—
—
—
0
0
65
261
2.86
11.72
4.3
4.3
1.93
1.95
mmol/l
0.01
52
207
190
1264
2.19
10.86
4.1
2.8
—
—
—
0
0
108
577
2.30
10.61
2.2
1.8
3.40
1.34
mg/l
0.65
87
453
201
1382
2.17
10.38
22.1
16.2
1.33
1.30
inr
0.14
51
398
156
978
2.13
10.19
4.7
3.8
443.56
101.34
e6/l
0.42
124
707
103
550
2.27
10.06
4.6
3.5
262.18
208.82
ng/l
0.12
85
453
18
17
11.13
9.91
2.8
2.7
35.00
48.60
%
—
10
10
144
885
2.12
9.82
4.5
2.5
—
—
—
0
0
14
8
18.21
9.48
1.2
1.0
—
—
—
0
0
56
232
2.70
9.43
7.8
9.0
—
—
—
0
0
96
510
2.25
9.41
2.6
1.4
2.28
2.58
g/l
0.41
69
304
224
1640
2.15
9.39
7.3
5.1
6.57
6.75
mmol/l
0.57
216
1537
19
25
8.00
8.77
1.1
1.3
—
—
—
0
0
13
8
16.84
8.62
2.2
1.5
—
—
—
0
0
82
425
2.24
8.44
1.8
2.1
—
—
—
0
0
83
436
2.21
8.25
3.5
3.1
1.80
1.92
e6/l
0.07
47
244
105
607
2.07
8.14
3.0
2.6
5.27
4.84
e6/l
0.09
96
543
36
127
3.06
8.09
2.2
3.5
470.19
1435.44
u/ml
0.41
26
110
158
1059
1.95
8.01
2.6
2.1
—
—
—
0
0
165
1130
1.92
7.77
2.2
2.0
88.06
93.29
pmol/l
0.74
100
587
101
585
2.05
7.73
3.5
2.9
490.41
566.73
mosm/kgh2o
3.58
91
491
19
50
3.97
6.63
4.3
3.7
52.37
58.10
%
0.71
19
50
110
688
1.90
6.59
1.5
1.5
18.29
20.84
nmol/l
1.22
97
572
155
1081
1.82
6.56
2.8
2.3
79.55
77.71
nmol/l
0.34
144
935
68
361
2.11
6.46
7.9
7.3
104.19
104.09
mmol/l
0.06
68
361
34
132
2.76
6.44
1.3
1.2
453.75
199.02
u/ml
0.70
28
116
15
23
6.78
6.41
2.7
2.5
—
—
—
0
0
53
257
2.27
6.30
2.8
2.2
30.39
33.55
u/l
0.26
44
209
130
871
1.81
6.19
2.7
2.6
50.42
62.03
u/l
1.27
115
807
14
21
6.91
6.10
1.4
1.3
—
—
—
0
0
93
563
1.91
6.09
1.7
1.7
1025.50
1205.13
nmol/l
1.47
75
413
105
663
1.86
6.03
1.5
1.4
—
—
—
0
0
61
321
2.11
5.91
2.5
4.5
43.76
43.33
ug/l
0.00
47
273
44
203
2.35
5.86
4.0
3.7
76.48
83.54
ng/l
0.25
38
179
17
35
5.06
5.82
1.1
1.0
—
—
—
0
0
16
42
3.95
5.60
1.1
1.7
—
—
—
0
0
17
37
4.79
5.57
1.1
1.1
—
—
—
0
0
131
902
1.75
5.55
4.1
3.1
1850.54
1578.35
ng/l
0.37
121
764
16
43
3.86
5.43
1.1
1.1
—
—
—
0
0
17
48
3.68
5.40
4.2
3.0
3.29
4.60
e9/l
2.09
17
48
18
54
3.47
5.24
1.2
1.6
8.77
214.51
e6/l
1.03
13
43
18
54
3.47
5.24
1.2
1.5
12.92
8.98
e6/l
0.14
12
42
58
317
2.01
5.05
1.6
1.3
1260.00
553.07
titre
0.69
12
75
228
1865
1.72
4.88
5.0
4.1
—
—
—
0
0
20
68
3.07
4.80
1.2
1.2
—
—
—
0
0
14
32
4.52
4.49
2.9
2.2
—
—
—
0
0
57
326
1.91
4.34
1.7
1.8
—
—
—
0
0
7
8
8.91
3.79
2.9
3.4
—
—
—
0
0
11
24
4.70
3.78
1.1
1.1
—
—
—
0
0
11
25
4.51
3.65
1.2
1.3
—
—
—
0
0
18
68
2.74
3.62
1.4
1.3
—
—
—
0
0
56
340
1.78
3.52
1.3
1.3
—
—
—
0
0
9
18
5.11
3.39
1.0
1.1
—
—
—
0
0
20
83
2.50
3.37
3.1
3.6
—
—
—
0
0
10
23
4.45
3.33
1.0
2.1
—
—
—
0
0
6
7
8.70
3.27
1.0
1.0
—
—
—
0
0
13
39
3.43
3.26
4.6
3.1
—
—
—
0
0
9
19
4.84
3.26
1.0
1.8
—
—
—
0
0
215
1819
1.53
3.25
5.4
4.4
—
—
—
0
0
12
37
3.33
2.96
7.8
4.2
—
—
—
0
0
11
32
3.52
2.92
1.4
1.5
—
—
—
0
0
7
13
5.48
2.88
2.1
1.5
—
—
—
0
0
7
13
5.48
2.88
2.7
1.3
—
—
—
0
0
12
39
3.15
2.80
1.3
1.7
—
—
—
0
0
9
23
3.99
2.79
1.4
1.7
—
—
—
0
0
57
371
1.65
2.79
1.5
1.3
—
—
—
0
0
19
85
2.31
2.76
1.2
1.2
—
—
—
0
0
5
6
8.44
2.76
1.0
1.0
—
—
—
0
0
37
219
1.78
2.54
4.7
3.8
—
—
—
0
0
13
51
2.61
2.47
1.2
1.9
—
—
—
0
0
113
876
1.44
2.47
3.6
3.2
—
—
—
0
0
286
2636
1.65
2.45
35.8
16.0
27.37
24.69
mg/l
0.82
265
2137
16
71
2.32
2.38
4.5
3.2
7.43
7.42
ph
0.62
16
63
23
119
2.00
2.37
1.2
1.2
—
—
—
0
0
60
836
0.65
2.30
3.3
3.0
—
—
—
0
0
10
34
3.00
2.30
1.9
1.9
89.07
89.21
%
—
10
34
49
329
1.57
2.12
8.2
9.2
0.96
1.25
mmol/l
0.22
42
268
5
10
5.06
2.08
4.2
2.6
13.42
13.57
%
—
5
10
27
155
1.81
2.07
1.3
1.7
—
—
—
0
0
93
716
1.42
2.07
5.5
4.2
0.00
0.00
estimate
-0.00
39
238
26
148
1.82
2.05
11.5
13.1
—
—
—
0
0
135
1111
1.36
2.01
4.6
4.0
27.65
42.15
ng/l
1.47
102
838
7
21
3.38
1.97
3.6
2.1
—
—
—
0
0
6
16
3.80
1.94
1.7
2.3
—
—
—
0
0
45
304
1.56
1.91
8.6
9.5
95.51
95.49
%
0.01
45
294
5
12
4.21
1.83
1.4
3.3
107.00
60.58
nmol/l
—
5
12
7
23
3.09
1.81
1.6
1.5
—
—
—
0
0
41
276
1.55
1.77
9.3
10.1
116.68
120.04
g/l
0.49
41
270
24
141
1.76
1.73
1.3
1.3
—
—
—
0
0
11
48
2.34
1.72
4.2
3.1
—
—
—
0
0
151
1287
1.32
1.71
5.0
3.9
0.00
0.00
estimate
0.50
41
267
153
1307
1.32
1.70
5.1
3.9
0.00
0.00
estimate
-0.00
41
234
12
55
2.23
1.69
2.5
1.9
4.19
4.85
mmol/24h
0.31
12
46
20
112
1.84
1.68
7.5
9.4
0.78
0.91
%
0.98
20
104
151
1291
1.31
1.66
6.6
5.2
0.00
0.00
estimate
-0.00
42
245
190
1680
1.31
1.62
3.5
3.1
67.10
51.62
u/l
0.92
172
1559
8
32
2.54
1.60
1.4
2.6
3.76
2.58
nmol/l
—
8
32
20
114
1.80
1.60
7.6
9.2
1.56
1.58
%
0.06
20
106
7
27
2.63
1.52
1.3
1.0
—
—
—
0
0
6
21
2.89
1.51
1.0
1.0
—
—
—
0
0
215
1945
1.30
1.49
4.3
3.7
14.88
14.90
pmol/l
0.03
195
1716
28
181
1.60
1.45
3.0
2.6
3.75
6.30
e9/l
0.95
22
144
9
39
2.34
1.44
1.4
1.5
—
—
—
0
0
12
61
2.00
1.34
1.2
1.1
—
—
—
0
0
14
76
1.88
1.32
9.6
2.8
2.07
1.67
mg/l
0.45
14
67
19
114
1.71
1.31
4.2
4.2
—
—
—
0
0
8
34
2.39
1.30
1.5
1.4
—
—
—
0
0
101
844
1.28
1.26
2.0
2.1
152.19
221.32
u/l
0.58
95
792
239
2547
0.77
1.23
4.3
4.6
1.34
1.45
mmol/l
4.67
213
2313
289
2753
1.41
1.23
35.5
18.6
139.27
139.64
mmol/l
1.95
283
2676
230
2459
0.79
1.19
6.0
6.1
40.35
40.47
mmol/mol
0.07
202
2259
289
2757
1.40
1.18
36.7
18.7
3.98
4.00
mmol/l
0.54
283
2679
68
544
1.32
1.17
1.2
1.2
0.50
1.42
u/ml
1.44
15
138
51
392
1.36
1.15
1.2
1.3
3.55
15.37
u/ml
1.83
15
147
292
2793
1.40
1.14
21.8
10.8
25.64
25.37
u/l
0.11
286
2684
248
2623
0.78
1.13
5.0
5.2
2.51
2.67
mmol/l
1.85
219
2379
242
2565
0.79
1.10
4.4
4.7
4.32
4.54
mmol/l
2.77
219
2348
11
59
1.89
1.08
3.5
5.2
—
—
—
0
0
7
33
2.14
1.06
1.0
1.2
—
—
—
0
0
85
711
1.26
1.04
4.1
3.6
—
—
—
0
0
28
197
1.46
1.04
6.4
6.7
—
—
—
0
0
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
13
76
1.74
1.00
1.6
1.5
281.13
278.10
ug/g
—
8
43
118
1029
1.23
1.00
4.9
3.6
5.50
5.76
ph
—
5
71
23
157
1.50
0.99
2.6
3.0
0.42
0.16
e6/l
0.38
23
152
26
185
1.44
0.92
9.3
9.3
25.37
24.53
mmol/l
0.72
26
176
11
181
0.59
0.90
1.5
1.4
—
—
—
0
0
35
267
1.35
0.85
2.0
2.5
2.76
6.53
ug/l
2.84
30
236
20
138
1.48
0.84
1.7
2.9
—
—
—
0
0
23
164
1.43
0.82
2.0
2.4
—
13.24
—
0
10
6
32
1.89
0.82
1.3
1.3
—
—
—
0
0
8
48
1.68
0.79
1.5
4.4
55.78
64.13
%
—
8
48
32
246
1.33
0.75
1.8
1.5
—
—
—
0
0
52
428
1.26
0.74
1.2
1.3
37.21
41.59
iu/ml
0.06
14
133
10
61
1.66
0.69
12.2
14.0
9.90
11.04
mmol/l
—
10
55
10
61
1.66
0.69
12.2
14.0
104.00
105.33
mmol/l
—
10
55
9
59
1.54
0.69
1.7
1.5
261.33
258.98
mu/l
—
9
52
235
2459
0.84
0.67
4.1
4.2
1.34
1.28
mmol/l
0.84
206
2226
25
189
1.35
0.67
1.3
1.4
—
—
—
0
0
41
333
1.26
0.66
1.9
1.5
—
—
—
0
0
5
28
1.80
0.66
1.2
1.2
—
—
—
0
0
68
590
1.19
0.60
5.7
3.9
—
—
—
0
0
0
21
0.00
0.60
0.0
2.3
—
—
—
0
0
8
53
1.52
0.59
2.4
2.4
—
—
—
0
0
10
65
1.56
0.56
6.8
2.8
—
—
—
0
0
13
181
0.71
0.54
3.5
3.0
—
—
—
0
0
9
61
1.49
0.54
2.1
1.6
2600.44
18330.47
e6/l
—
9
47
6
39
1.55
0.53
1.5
1.5
—
—
—
0
0
19
144
1.34
0.52
2.6
2.4
—
—
—
0
0
12
84
1.44
0.50
1.3
2.4
71.42
57.12
ug/min
—
5
47
249
2401
1.15
0.49
5.2
4.5
2.00
1.97
mu/l
0.13
229
2153
65
574
1.17
0.48
5.4
4.3
1.02
1.02
kg/l
—
7
85
23
185
1.26
0.43
1.2
1.2
—
—
—
0
0
5
34
1.48
0.40
2.4
3.0
—
—
—
0
0
10
71
1.42
0.39
1.5
1.3
—
—
—
0
0
8
115
0.69
0.37
2.1
1.5
—
—
—
0
0
37
321
1.17
0.35
1.4
1.3
—
—
—
0
0
12
91
1.33
0.34
1.0
1.1
—
—
—
0
0
13
100
1.31
0.34
2.9
3.4
0.12
0.18
g/l
—
8
36
20
242
0.82
0.34
1.8
1.6
—
—
—
0
0
65
595
1.12
0.30
1.6
1.8
469.04
438.36
pmol/l
0.40
53
478
91
861
1.08
0.22
3.0
3.1
7.13
7.44
mmol/l
0.31
71
711
0
11
0.00
0.21
0.0
8.5
—
0.63
—
0
11
0
10
0.00
0.21
0.0
1.1
—
2.57
—
0
10
0
12
0.00
0.21
0.0
14.7
—
1760.33
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
261
2566
1.08
0.20
4.8
4.8
5.97
6.02
mmol/l
0.23
237
2317
0
14
0.00
0.20
0.0
1.6
—
0.77
—
0
8
0
14
0.00
0.20
0.0
1.3
—
4.63
—
0
7
6
50
1.20
0.20
1.0
1.2
—
—
—
0
0
23
203
1.14
0.19
2.8
2.3
9.96
12.93
nmol/l
1.07
23
185
74
702
1.07
0.17
1.5
1.7
1.36
1.32
mmol/l
0.22
63
572
293
2901
1.09
0.15
46.9
23.3
37.48
40.00
%
10.19
275
2707
293
2902
1.09
0.15
46.9
23.1
234.44
242.89
e9/l
0.96
283
2824
9
83
1.09
0.15
1.2
1.1
—
—
—
0
0
293
2903
1.08
0.14
46.8
23.1
4.18
4.47
e12/l
13.49
282
2815
12
103
1.17
0.14
1.5
2.0
—
—
—
0
0
293
2904
1.08
0.13
46.9
23.1
7.83
6.75
e9/l
1.18
281
2816
276
2732
1.06
0.12
24.4
14.9
—
—
—
0
0
11
95
1.16
0.12
1.9
1.6
—
—
—
0
0
110
1070
1.04
0.11
5.1
5.2
3.97
2.34
ug/l
0.46
102
948
30
281
1.07
0.10
5.3
4.3
—
—
—
0
0
80
826
0.96
0.09
3.4
3.2
471.63
197.94
mg/l
0.26
53
554
6
58
1.04
0.08
1.5
1.8
156.50
226.15
pmol/l
—
6
53
5
62
0.80
0.08
1.0
1.1
—
—
—
0
0
13
142
0.91
0.06
19.7
3.8
—
—
—
0
0
14
151
0.92
0.05
1.4
1.2
—
—
—
0
0
13
140
0.93
0.04
4.6
3.8
—
—
—
0
0
60
611
0.98
0.03
2.9
3.1
0.58
0.80
ug/l
2.45
47
412
86
868
0.99
0.01
3.7
3.8
5.17
7.86
mg/mmol
1.00
57
559
25
244
1.03
0.00
5.4
3.5
—
—
—
0
0
85
856
0.99
0.00
5.2
4.2
—
—
—
0
0
20
198
1.01
0.00
15.2
3.7
5.05
5.09
kpa
0.05
20
192
18
177
1.02
0.00
1.4
1.5
—
—
—
0
0
31
307
1.01
0.00
2.7
2.3
156.36
138.72
ug/g
0.07
24
237
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
-0.00
6.0
2.6
—
—
—
0
0
7
79
0.88
-0.00
1.6
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
19.39
—
0
7
0
7
0.00
-0.00
0.0
2.1
—
2654.14
—
0
7
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
83
0.96
-0.00
5.4
4.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
52.83
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
38.00
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_PRIMARY_LYMPHOID_HEMATOPOIETIC_NAS – Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).